JP JAZZ PHARMACEUTICALS Trademark

Trademark Overview


On Friday, August 30, 2024, a trademark application was filed for JP JAZZ PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the JP JAZZ PHARMACEUTICALS trademark a serial number of 98726519. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 17, 2024. This trademark is owned by Jazz Pharmaceuticals Ireland Limited. The JP JAZZ PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, pain, sleep disorders, narcolepsy, schizophrenia, and for use in oncology and hematology; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations acting on the central nervous system; pain relief medication; pharmaceutical preparations for use in the treatment and/or management of sleep disorders; pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for use in oncology and hematology
jp jazz pharmaceuticals

General Information


Serial Number98726519
Word MarkJP JAZZ PHARMACEUTICALS
Filing DateFriday, August 30, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements


Description of MarkThe mark consists of "JAZZ PHARMACEUTICALS" positioned to the right of a circular logo with a stylized depiction of the letters "JP" which vertically splits the circle.
Goods and ServicesPharmaceuticals for the treatment and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, pain, sleep disorders, narcolepsy, schizophrenia, and for use in oncology and hematology; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations acting on the central nervous system; pain relief medication; pharmaceutical preparations for use in the treatment and/or management of sleep disorders; pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for use in oncology and hematology
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 30, 2024
Primary Code005
First Use Anywhere DateFriday, June 7, 2024
First Use In Commerce DateFriday, June 7, 2024

Trademark Owner History


Party NameJazz Pharmaceuticals Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin
IE

Party NameJazz Pharmaceuticals Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin
IE

Trademark Events


Event DateEvent Description
Friday, August 30, 2024NEW APPLICATION ENTERED
Sunday, November 10, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, November 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2024ASSIGNED TO EXAMINER
Friday, November 22, 2024EXAMINERS AMENDMENT E-MAILED
Friday, November 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 22, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 22, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, November 22, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED